Blog
22 August 2026
Breakthrough Personalized mRNA Vaccine Boosts Melanoma Survival Rates
Discover how a personalized mRNA vaccine combined with immunotherapy improves survival rates in melanoma patients after surgery.
Read more
Micro-Gauge Needles with LDSI Reduce Pain and Waste in Botox Injections
Discover how micro-gauge needles with LDSI reduce pain, bruising, and product waste in Botox injections for a more comfortable, efficient...
24 08 2026
Read more
Understanding and Treating Port Wine Stains: Latest Advances Explained
Discover the latest advances in understanding and treating port wine stains, including expert insights and effective therapies like pulsed dye...
21 08 2026
Read more
2026 Elevate Derm Summer Conference Day 3 Recap: Key Insights & Advances
Discover key insights from Elevate Derm Summer 2026 Day 3, featuring advances in alopecia, atopic dermatitis, AI, and practical dermatology...
20 08 2026
Read more
Hair Loss Awareness Month: Identifying the Real Cause for Effective Treatment
Discover the real causes of hair loss this Hair Loss Awareness Month and learn how identifying symptoms leads to effective,...
19 08 2026
Read more
Social Media Cosmetic Trends Linked to Skin Barrier Damage and Acne Delays
Social media-driven cosmetic trends link to skin barrier damage, delayed acne care, and worse severity. Learn how product choices impact...
18 08 2026
Read more
Chronic Spontaneous Urticaria and C1 Inhibitor Deficiency: A Diagnostic Challenge
Explore the diagnostic challenge of chronic spontaneous urticaria and C1 inhibitor deficiency in patients with persistent wheals, throat tightness, and...
17 08 2026
Read more
Hydrocolloid Pimple Patches: Do They Really Work for Acne?
Discover if hydrocolloid pimple patches really work for acne. We break down the science behind this viral skincare trend and...
16 08 2026
Read more
Zasocitinib’s Unique TYK2 Targeting Shows Promise for Palmoplantar Psoriasis
Discover how zasocitinib’s unique TYK2 targeting offers new hope for treating moderate palmoplantar psoriasis with promising phase 3 trial results.
11 08 2026
Read more